Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01819116 · ClinicalTrials.gov registry record
Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor
A clinical trial of Brain Death, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT01819116: Completed study of Brain Death, sponsored by The Cleveland Clinic.
NCT01819116 is a study of Brain Death that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01819116, a study of Brain Death, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to quantify the association between tissue oxygen saturation (StO2) during the donor management phase of the Death by Neurological Criteria (DNC) organ donor and the number of organs transplanted per donor.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
What the finished NCT01819116 record still lists
NCT01819116 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 1 condition, with Brain Death appearing as the primary indexed condition, and to 0 interventions.
NCT01819116 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01819116 about?
NCT01819116 is a clinical study titled "Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor". The objective of this study is to quantify the association between tissue oxygen saturation (StO2) during the donor management phase of the Death by Neurological Criteria (DNC) organ donor and the number of organs transplanted per donor.
What is the current status of trial NCT01819116?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2013-04. Estimated completion is 2014-03.
What conditions does trial NCT01819116 study?
This clinical trial studies the following conditions: Brain Death.
Who is sponsoring clinical trial NCT01819116?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01819116 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Death
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia